Drug application
LINCOCIN (LINCOMYCIN HYDROCHLORIDE)
Drugs@FDA NDA 050317 · PFIZER
Key facts
| Drug name | LINCOCIN |
|---|---|
| Active ingredients | LINCOMYCIN HYDROCHLORIDE |
| Application type | NDA |
| Application number | 050317 |
| Company | PFIZER |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | EQ 300MG BASE/ML |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | Yes |
| Latest submission status date | Dec 29, 1964 |
At a glance
- 1–9 Submissions
- 100–999 Supplements
- 1–9 Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: